Global Hospital Acquired Disease Testing Market, by Test Type (Urinary Tract Infection, Surgical Site Infection, Pneumonia, Blood Stream Infection, Methicillin-resistant Staphylococcus Aureus, and others) and by Region - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

  • Published On : Oct 2017 |
  • Pages : 140 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Hospital acquired Disease Testing – Hospital or Mortuary

Hospital acquired disease or nosocomial infection is a localized or systemic condition in patients occurred due to adverse reaction caused by infectious toxin agents under medical care and were absent at the time of admission. Hospitals acquired infections results in prolonged hospital stay, antimicrobial resistance, long-term disabilities, and increase mortality rate. Pathogens responsible for nosocomial infections include viruses, fungal parasites, and bacteria.

Hospital acquired infection is emerging as a major burden for society, patients, and healthcare management

Hospital acquired disease could be catheter-related blood stream infection, surgical site infection, ventilator-associated pneumonia, and catheter-associated urinary tract infection. These infection occurring in emerging economies globally. According Asia Pacific Journal of Tropical Medicine, 2017, Nosocomial infections account for around 10% in emerging economies and around 7% in developed economies out of all the infections. According to the World Health Organization (WHO), 2011, approximately around 15% patients hospitalized suffer from above mentioned infections, due to exposure to pathogens through different sources, such as healthcare staff and infected patients. Newborns, especially in emerging economies are also at high risk to develop hospital acquired infection. According to WHO, 2011, the infection rate in newborns is 20 times higher in emerging economies as compared to high income economies.

Hospital acquired infection is emerging as a major burden for society, patients, and healthcare management. Nosocomial infections could be prevented by practicing infection control programs and adopting antimicrobial control policies. For instance, National Health & Medical Research Council Australia (NHMRC), 2002 provided critical guidelines for the management of infections, prevention, and control in healthcare organizations.

The global hospital acquired disease testing market was valued at US$ 539 million in 2016 and is expected to witness a robust CAGR of 19.70% over the forecast period (2017 - 2025).

Global Hospital Acquired Disease Testing Market, by Region, 2016 (US$ Mn)

hospital acquired disease testing

Source: Coherent Market Insights 2017

Antibodies resistance and extended hospitalization is expected to propel the growth of hospital acquired disease testing in near future

The most common nosocomial infections across the globe are the surgical wounds, urinary tract infections, and lower respiratory tract infections. The highest prevalence of these infections occurs in intensive care units, orthopedic, and acute surgical ward. Out of the mentioned infections, the urinary tract infections is the most common in the patients dwelling with urinary catheter, due to urethra is located close to the anus, which increases the changes of invasions of bacteria from large intestine into the urinary tracts. Due to these infections, the costs and the antibiotic resistance increases with extended hospitalization, which in turn expected to propel the growth of hospital acquired disease testing market. The popular techniques used for preventions, diagnosis, and testing of hospital acquired diseases are microarray, PCR, and solid phase hybridization.  

North America and Europe are expected to dominate the hospital acquired disease testing market owing to encouraging government initiatives, regulatory guidelines and reimbursement scenario. Medicare and private insurance companies are eliminating the reimbursement rate due to high rate of hospital acquired infection (HAI) incidence during 2014 and 2015, adding economic pressures on hospitals to reduce hospital acquired diseases. Ion the other hand, unhygienic conditions and practices in developing and underdeveloped economies is resulting in higher incidences of HAI in these regions. Thus, generating a need for HAI testing in this regions during the forecast period.

The key market players are Diatherix laboratories, Life technologies, Cantel Medical Corporation Meridian Biosciences, Qiagen GmbH, Nordion, Roche, and Cepheid & others.

Hospital-acquired diseases are those infections that are acquired by the patient under medical care. The most common type of hospital-acquired infections are urinary tract infection, bloodstream infections, MRSA, pneumococcal infections, and gastrointestinal illnesses. An increasing rate of morbidity related to hospital-acquired infections worldwide is the major driver for the growth of hospital-acquired disease testing market. Devices employed in modern care facilities, such as catheters and ventilators are also associated with the cause of these infections.

Market Dynamics

According to World health organization (WHO), 2011, highest prevalence of hospital-acquired infections occur in intensive care units, orthopedic, and acute surgical ward.  According to an article in Journal of Nursing & Health Sciences, 2016, the prevalence rate of hospital-acquired diseases is approximately 5.1% to 11.6% in emerging economies. Around 1.7 million people are affected by HAI in the U.S. itself accounting for 9.9 infections per 1000 patients a day. High prevalence rate is the key factor propelling the growth of market in near future.

Urinary tract infection is the most common infection, owing to its high risk in the patients indwelling with urinary catheter, which leads to increase chance of bacterial invasion from the anus to the urinary tract and promotes colonization of bacteria.

The most common techniques used for diagnosis of the hospital-associated infections are solid phase hybridization, PCR, and microarrays. Curetis Unyvero System, launched in 2012, a new molecular device used for rapid detection microorganism and antibiotic resistance gene. Antibiotic resistance is also the major concern factor associated with hospital-acquired Disease testing.

Key features of the study:

  • This report provides an in-depth analysis of global hospital-acquired disease testing market, provides market size (US$ 539 Million), and Cumulative Annual Growth Rate (19.70 %) for the forecast period (2017 – 2025), considering 2016 as the base year.
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players.
  • It profiles leading players in the global hospital-acquired disease testing market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans.
  • Key companies covered as a part of this study include Diatherix laboratories, Life technologies, Cantel Medical Corporation Meridian Biosciences, Qiagen GmbH, Nordion, and Roche Cepheid.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics.
  • The global hospital-acquired disease testing market report caters to various stakeholders in this industry including investors, suppliers, hospital-acquired disease testing manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision making through the various strategy matrices used in analyzing the hospital acquired disease testing and consumables market.

Detailed Segmentation:

  • Global Hospital-acquired Disease Testing  market, By Test Type :
    • Urinary Tract Infection
    • Surgical Site Infection
    • Pneumonia Stents
    • Blood Stream Infection
    • Methicillin-resistant Staphylococcus Aureus
    • Others
  • Global Hospital-acquired Disease Testing market, By Geography:
    • North America
      • By Test Type:
        • Urinary Tract Infection
        • Surgical Site Infection
        • Pneumonia Stents
        • Blood Stream Infection
        • Methicillin-resistant Staphylococcus Aureus
        • Others
      • By Country
        • U.S.
        • Canada
    • Europe
      • By Test Type:
        • Urinary Tract Infection
        • Surgical Site Infection
        • Pneumonia Stents
        • Blood Stream Infection
        • Methicillin-resistant Staphylococcus Aureus
        • Others
      • By Country
        • U.K.
        • Germany
        • Italy
        • France
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Test Type:
        • Urinary Tract Infection
        • Surgical Site Infection
        • Pneumonia Stents
        • Blood Stream Infection
        • Methicillin-resistant Staphylococcus Aureus
        • Others
      • By Country
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Test Type:
        • Urinary Tract Infection
        • Surgical Site Infection
        • Pneumonia Stents
        • Blood Stream Infection
        • Methicillin-resistant Staphylococcus Aureus
        • Others
      • By Country
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East
      • By Test Type:
        • Urinary Tract Infection
        • Surgical Site Infection
        • Pneumonia Stents
        • Blood Stream Infection
        • Methicillin-resistant Staphylococcus Aureus
        • Others
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Test Type:
        • Urinary Tract Infection
        • Surgical Site Infection
        • Pneumonia Stents
        • Blood Stream Infection
        • Methicillin-resistant Staphylococcus Aureus
        • Others
      • By Country
        • North Africa
        • Central Africa
        • South Africa
  • Company Profiles
    • Diatherix laboratories*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
      • Future Plans
    • Life technologies
    • Cantel Medical Corporation
    • Meridian Biosciences
    • Nordion
    • Qiagen GmbH
    • Roche
    • Cepheid

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet By Test Type
      • Market Snippet By Region  
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Regulatory Scenario
    • Industry Trend
    • Merger and Acquisitions
    • Epidemiology
    • Preventive Initiatives
  4. Global Hospital Acquired Disease Testing Market, By Test type, 2015 - 2025 (US$ Million)
    • Introduction
      • Market Share Analysis, 2016 and 2025 (%)
      • Y-O-Y Growth Analysis, 2015 - 2025
      • Segment Trends
    • Urinary Tract Infection
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
    • Surgical Site Infection
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
    • Pneumonia
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
    • Blood Stream Infection
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
    • Methicillin-resistant Staphylococcus Aureus (MRSA)
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-O-Y Growth, 2015 - 2025, (US$ Million)
  5. Global Hospital Acquired Disease Testing  Market, By Regions, 2015 - 2025 (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2016 and 2025 (%)
      • Y-o-Y Growth Analysis, For Regions, 2015 – 2025
      • Regional Trends
    • North America
      • Market Size and Forecast, By Test Type, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Test Type, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Test Type, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of APAC
    • Latin America
      • Market Size and Forecast, By Test Type, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East
      • Market Size and Forecast, By Test Type, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Test Type, 2015 - 2025 (US$ Mn)
      • Market Size and Forecast, By Country, 2015 - 2025 (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
  6. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • Diatherix laboratories
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Life technologies
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Cantel Medical Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Meridian Biosciences
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Nordion
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Qiagen GmbH
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Roche
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
      • Cepheid
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Developments/Updates
        • Future Plans
    • Analyst Views
  7. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 33 market data tables and 30 figures on "Hospital Acquired Disease Testing Market” - Global forecast to 2025”.

Research Methodology

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

  • Primary Research (Trade Surveys and Experts Interviews)
  • Desk Research
  • Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.


Smiley face

Coherent Market Insights desk research is based on a principle set of research techniques:

  • National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.
  • Multinational level desk research: The research team keeps a track of multinational players, global regulatory bodies, global trade associations, and global organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

  • Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.
  • Trade association, National and international media and trade press.
  • Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.
  • Scientific journals, and other technical magazines and whitepapers.

Smiley face

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

  • Micro-economic indicators
  • Macro-economic indicators
  • Environmental indicators
  • Socio-political indicators
  • Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

  • It provides first-hand information on the market dynamics, outlook, and growth parameters.
  • Industry experts validates the estimates which helps the company to cement the on-going research study.
  • Primary research includes online surveys, face-to face interviews, and telephonic interviews.

The primary research is conducted with the ecosystem players including, but not limited to:

  • Raw Material Suppliers
  • Manufacturers
  • System Integrators
  • Distributors
  • End-users

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.